Description
This formulation combines BPC-157 with L-Arginine, an amino acid that serves as a substrate for nitric oxide synthase. Preclinical research has explored how arginine co-administration may influence BPC-157’s angiogenic and cytoprotective effects through the NO signaling pathway.
Independently tested to 99%+ purity via HPLC and MS/MS. COA included.
For research use only. Not for human or veterinary consumption.




